Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1333340-85-4

C23H27N5O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1333340-85-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1333340-85-4 Structure

  • Basic information

    1. Product Name: C23H27N5O2
    2. Synonyms: C23H27N5O2
    3. CAS NO:1333340-85-4
    4. Molecular Formula:
    5. Molecular Weight: 405.5
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1333340-85-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C23H27N5O2(CAS DataBase Reference)
    10. NIST Chemistry Reference: C23H27N5O2(1333340-85-4)
    11. EPA Substance Registry System: C23H27N5O2(1333340-85-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1333340-85-4(Hazardous Substances Data)

1333340-85-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1333340-85-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,3,3,4 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1333340-85:
(9*1)+(8*3)+(7*3)+(6*3)+(5*3)+(4*4)+(3*0)+(2*8)+(1*5)=124
124 % 10 = 4
So 1333340-85-4 is a valid CAS Registry Number.

1333340-85-4Relevant articles and documents

3,5-Diarylazoles as novel and selective inhibitors of protein kinase D

Gamber, Gabriel G.,Meredith, Erik,Zhu, Qingming,Yan, Wanlin,Rao, Chang,Capparelli, Michael,Burgis, Robin,Enyedy, Istvan,Zhang, Ji-Hu,Soldermann, Nicolas,Beattie, Kimberley,Rozhitskaya, Olga,Koch, Keith A.,Pagratis, Nikos,Hosagrahara, Vinayak,Vega, Richard B.,McKinsey, Timothy A.,Monovich, Lauren

, p. 1447 - 1451 (2011/04/16)

The synthesis and preliminary studies of the SAR of novel 3,5-diarylazole inhibitors of Protein Kinase D (PKD) are reported. Notably, optimized compounds in this class have been found to be active in cellular assays of phosphorylation-dependant HDAC5 nuclear export, orally bioavailable, and highly selective versus a panel of additional putative histone deacetylase (HDAC) kinases. Therefore these compounds could provide attractive tools for the further study of PKD / HDAC5 signaling.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1333340-85-4